Clinical trial · Interventional
Vitamin D Levels in Women With Polycystic Ovary Syndrome
Assessment of Serum Vitamin D Levels in Women With Polycystic Ovary Syndrome
NCT05101811CI-TRIAL-00054779completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%. Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Vitamin D level assessment | Device | — | UNRESOLVED |
| Vitamin D Levels measurement using chemiluminescent assay | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Control women without polycystic ovary syndrome
- description
- Normal fertile women without polycystic ovary syndrome
- interventionNames
- Drug: Vitamin D Levels measurement using chemiluminescent assay
- Device: Vitamin D level assessment
- type
- EXPERIMENTAL
- label
- Case women with polycystic ovary syndrome
- description
- Women with polycystic ovary syndrome
- interventionNames
- Drug: Vitamin D Levels measurement using chemiluminescent assay
- Device: Vitamin D level assessment
Primary outcomes (1)
- measure
- Levels of vitamin D in Polycystic ovary syndrome
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 35 Years
Show eligibility criteria text
Inclusion criteria: * Hyperandrogenism * Polycystic ovary syndrome Exclusion Criteria: * Thyroid disease * Parathyroid disease * Diabetes Mellitus * Cushing syndrome * Congenital adrenal hyperplasia * Hyperprolactinemia * Renal, liver or chronic disease
References
Publications (0)
Data not yet available
No reference posted for this study.